Wedbush Starts TCR2 Therapeutics (TCRR) at Outperform

March 11, 2019 6:46 AM EDT
Get Alerts TCRR Hot Sheet
Price: $13.00 +2.44%

Rating Summary:
    10 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 26 | New: 41
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten initiates coverage on TCR2 Therapeutics (NASDAQ: TCRR) with a Outperform rating and a price target of $28.00.

For an analyst ratings summary and ratings history on TCR2 Therapeutics click here. For more ratings news on TCR2 Therapeutics click here.

Shares of TCR2 Therapeutics closed at $15.64 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage